SCHEMBL22999775

SCHEMBL22999775

CCOC(=O)CCN(C(=O)CC(=O)OCC)C1CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.39
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GLA P06280 1/20 0.36
RECQL P46063 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
EPHX1 P07099 1/20 0.34
NAMPT P43490 1/20 0.34
GPR119 Q8TDV5 2/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15297554 0.89 NR1H2 (0.40) NR1H2DDB1CRBNALDH1A1HPGD
SCHEMBL22999796 0.84 EPHX1 (0.42) ALDH1A1HPGDRECQLTSHRMEN1
SCHEMBL23021088 0.79 GPR119 (0.39) ALDH1A1HPGDKDM4EGLARECQL
SCHEMBL15285587 0.79 NR1H2 (0.42) NR1H2DDB1CRBNALDH1A1HPGD
SCHEMBL8208172 0.78 NR1H2 (0.46) NR1H2ALDH1A1HPGDRECQLTSHR
SCHEMBL19448253 0.77 USP30 (0.45) DDB1CRBNALDH1A1HPGDKDM4E
SCHEMBL19719417 0.77 USP30 (0.45) DDB1CRBNALDH1A1HPGDKDM4E
SCHEMBL15297743 0.77 GPR119 (0.43) ALDH1A1HPGDRECQLTSHRMEN1
SCHEMBL22323081 0.77 GAA (0.45) ALDH1A1TSHRMEN1KMT2AUSP2
SCHEMBL22216156 0.76 MGAM (0.44) ALDH1A1KDM4ETSHRLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021032323-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES GALAPAGOS NV (BE) 2021-02-25 WO disclosed
WO-2021032323-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES GALAPAGOS NV (BE) 2021-02-25 WO disclosed
EP-3782997-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES Galapagos N.V. (BE) 2021-02-24 EP disclosed
EP-3782997-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES Galapagos N.V. (BE) 2021-02-24 EP disclosed